• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Econ . Epidemiology and economic burden of medically attended influenza and influenza-like illness in Germany, 2016-2019

tetano

Editor, Senior Moderator
J Med Econ


. 2026 Dec;29(1):972-985.
doi: 10.1080/13696998.2026.2644765. Epub 2026 Mar 25.
Epidemiology and economic burden of medically attended influenza and influenza-like illness in Germany, 2016-2019

Anna C Meyer[SUP] 1 [/SUP], Julian Witte[SUP] 2 [/SUP], Manuel Batram[SUP] 2 [/SUP], José Bartelt-Hofer[SUP] 3 [/SUP], Mathieu Bangert[SUP] 3 [/SUP], Marie Schild[SUP] 1 [/SUP], Ursula Marschall[SUP] 4 [/SUP], Wolfgang Greiner[SUP] 5 [/SUP], Jörg Schelling[SUP] 6 [/SUP], Oliver Damm[SUP] 1 [/SUP]


Affiliations
Free article Abstract

Aims: Older adults and individuals with certain underlying conditions are at elevated risk of severe influenza complications. This study quantifies the burden of influenza and influenza-like illness (ILI) in Germany focusing on these high-risk groups.
Methods: This cohort study is based on claims data of a large statutory health insurance fund. Influenza/ILI was identified through International Classification of Diseases version 10 (ICD-10) codes J09-J11. Among insured individuals, the incidence of medically attended influenza/ILI, hospitalizations, complications, and direct healthcare costs were estimated for three consecutive influenza seasons from 2016-2017 to 2018-2019. Healthcare resource use, complications, and costs attributable to influenza were estimated through comparison with a matched control group. Analyses were stratified by age and prevalence of underlying conditions.
Results: Approximately 7 million individuals were included in each season. Influenza/ILI incidence decreased with age, but hospitalizations were most common among older adults. One in five cases aged 80+ years was hospitalized. In all age groups, individuals with underlying conditions had a higher incidence of influenza/ILI and of complications than those without underlying conditions. Direct costs per influenza/ILI case ranged from €133.28 (2016-2017) to €218.99 (2018-2019) and were higher in older adults and in individuals with underlying conditions.
Limitations: Underdiagnosis and misclassification of influenza in administrative claims may occur, particularly in the outpatient setting. Only selected complications were examined; exclusion of cardiovascular and neurological consequences likely results in an underestimation of the influenza/ILI burden. Indirect costs, e.g. through productivity losses are not considered.
Conclusions: Influenza/ILI significantly impacts the German healthcare system, with older adults and individuals with underlying conditions contributing disproportionately to the observed burden. Risks of severe outcomes and direct costs are highest in older adults, particularly those aged 80+ years, while children with underlying conditions also contribute substantially to the observed burden. These groups are important targets for preventive interventions.

Keywords: I10; I18; Influenza; ageing; claims data; cost of illness; epidemiology; health economics; risk groups.

 
Back
Top